Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
- S. Conti, B. Costa, M. Colleoni, D. Parolaro, G. Giagnoni
- Medicine, ChemistryBritish journal of pharmacology
- 1 January 2002
TLDR
The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and…
- B. Costa, F. Comelli, I. Bettoni, M. Colleoni, G. Giagnoni
- BiologyPAIN
- 31 October 2008
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
- B. Costa, G. Giagnoni, C. Franke, A. E. Trovato, M. Colleoni
- Biology, ChemistryBritish journal of pharmacology
- 1 September 2004
TLDR
Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo‐oxygenase systems
- B. Costa, S. Conti, G. Giagnoni, M. Colleoni
- Medicine, ChemistryBritish journal of pharmacology
- 1 October 2002
TLDR
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
- B. Costa, A. E. Trovato, F. Comelli, G. Giagnoni, M. Colleoni
- Biology, MedicineEuropean journal of pharmacology
- 5 February 2007
AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
- B. Costa, D. Siniscalco, G. Giagnoni
- Biology, MedicineBritish journal of pharmacology
- 1 August 2006
TLDR
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw
- B. Costa, M. Colleoni, G. Giagnoni
- Medicine, BiologyNaunyn-Schmiedeberg's Archives of Pharmacology
- 12 February 2004
TLDR
The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in…
- C. Martucci, A. E. Trovato, M. Colleoni
- Biology, MedicinePAIN®
- 1 June 2008
Repeated treatment with the synthetic cannabinoid WIN 55,212‐2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain
- B. Costa, M. Colleoni, G. Giagnoni
- Biology, PsychologyBritish journal of pharmacology
- 1 January 2004
TLDR
The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation
- F. Comelli, G. Giagnoni, I. Bettoni, M. Colleoni, B. Costa
- BiologyBritish journal of pharmacology
- 1 November 2007
TLDR
...
...